Health charity PATH has developed a formulation to stop vaccines suffering from freeze damage, which it believes will help ensure products are fully potent when they reach their destination.
Indian pharma firm Panacea Biotec has taken a 10 percent stake in
UK-based vaccine maker Cambridge Biostability (CBL) for £1.9m
(€1.4m) under a new joint venture deal signed between the two
companies.
GlaxoSmithKline (GSK), a major player in vaccine manufacturing, is
set to inaugurate a €100m vaccine production plant on Friday in a
Hungarian city 30Km northeast of Budapest.
A consortium of British private companies and a university facility
has been awarded $2.6m (€2.13m) by the UK's Department of Trade and
Industry (DTI) to produce a slow release vaccine which will
eliminate the need for booster...